RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The RBC report for April-21-2016I love shorts' distortion. When CXR bought Donnatal, the drug was not on FDA's list and was still generating revenues of USD$50M. It was never on the FDA but I love how you try to distort reality. It's like trying to create panic because McDonald's doesn't sell pizzas so Domino will drive them to bankruptcy.
Lattice wrote: OK dudsy, I took your bait and went to drugs.com. I did the search thing on Donnatal. This is what I see at first:
"Donnatal: Elixer Perscribing Information
This drug has not been found by FDA to be sale and effective and this labelling has not been approved by the FDA"
So right there I stopped researching, because as far as I know, Donnatal is deemed safe and non-addictive (although up for FDA review for efficacy). Are you a short that you would send me to a site that says Donnatal is not safe? The posters who cheerlead this stock are mind boggling.